Related Experiment Video
Updated: Feb 17, 2026
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Association between platelet levels and bleeding events in patients with acute-on-chronic liver failure treated with
Li Yang1,2, Fang Chen1, Lingyao Du1
1Center of Infectious Diseases, West China Hospital of Sichuan University, Chengdu, China.
Background:
Platelet reduction is associated with an increased risk of bleeding in patients with chronic liver disease. However, the association between platelet levels and bleeding events in patients with liver failure treated with an artificial liver support system (ALSS) remains unclear.
Methods:
This retrospective study included patients with acute-on-chronic liver failure (ACLF) who received ALSS treatment. Logistic and linear regression analyses were employed to assess the association between platelet levels and bleeding events during hospitalization and the relationship between sessions of ALSS treatment and platelet reduction rates.
Results:
We included 262 patients, of whom 56 (21.4%) experienced bleeding events during hospitalization. Baseline platelet levels in patients with bleeding events were significantly lower than those in patients without bleeding events (59.0 (39.0 ~ 89.3) × 109/L vs. 88.5 (57.0 ~ 121.0) × 109/L; p < 0.001). Baseline platelet levels were negatively associated with bleeding events (adjusted OR, 0.986; 95% CI, 0.976-0.996; p = 0.006), whereas platelet reduction rates and final platelet levels were not significantly associated with bleeding events (all p > 0.05). Compared to patients with baseline platelet grade 0, the risk of bleeding was significantly higher compared to those with baseline platelet grade 1 (adjusted OR: 3.21, 95% CI: 1.20 ~ 8.59, p = 0.002) and grade 2 (adjusted OR: 7.20, 95% CI: 2.28 ~ 21.43, p = 0.001), as well as in the combined group of grades 2 and 3 (adjusted OR: 8.43, 95% CI: 2.96 ~ 23.99, p < 0.001). The number of ALSS treatment sessions was not significantly associated with platelet reduction rates (p > 0.05).
Conclusion:
Patients with ACLF who underwent ALSS treatment with lower baseline platelet levels were at an increased risk of bleeding during hospitalization, whereas the platelet reduction rate was not independently associated with bleeding risk. These findings underscore the importance of baseline platelet count rather than platelet reduction for early risk stratification in patients with ACLF.
More Related Videos
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
04:37Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
01:22Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:18Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
01:28Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
01:24Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.